A Phase 4, 8-week, Double-blind, Randomized Study Comparing Switching to Duloxetine or Escitalopram in Patients With Major Depressive Disorder and Residual Apathy in the Absence of Depressed Mood
收藏DataCite Commons2025-11-24 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004471/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to provide a comparison of the apathy, depression, and functional outcomes associated with switching to duloxetine or escitalopram in patients who have previously responded to treatment with a selective serotonin reuptake inhibitor (SSRI) for major depressive disorder and who have residual apathy in the absence of depressed mood.
提供机构：
Vivli
创建时间：
2019-09-09
